1 |
Wolf G, Singh S, Blakolmer K, Lerer L, Lifschytz T, Heresco-Levy U, Lotan A, Lerer B. Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation. Mol Psychiatry 2023;28:44-58. [PMID: 36280752 DOI: 10.1038/s41380-022-01832-z] [Reference Citation Analysis]
|
2 |
Arumugham SS, Praharaj SK, Shreekantiah U, Sreeraj VS, Roy C, Shenoy S, Purohith AN, Chithra U, Bagali KB, Venkataramaiah S, Nanjundaiah GKK, Thennarasu K, Kumar CN, Goyal N, Das B, Mehta UM, Muralidharan K, Venkatasubramanian G, Sinha P, Thirthalli J. Clinical efficacy and neurobiological correlates of electroconvulsive therapy in patients with clozapine-resistant/intolerant schizophrenia: study protocol of multi-site parallel arm double-blind randomized sham-controlled study. Wellcome Open Res 2022;7:212. [DOI: 10.12688/wellcomeopenres.18028.2] [Reference Citation Analysis]
|
3 |
Wijnen VJM, Oudewortel L, van Luijtelaar G, Witlox J, Slooter AJC, van Gool WA. Feasibility and potential of a bedside mini-EEG for diagnosing delirium superimposed on dementia. Clin Neurophysiol 2022;142:181-9. [PMID: 36041344 DOI: 10.1016/j.clinph.2022.08.002] [Reference Citation Analysis]
|
4 |
Arumugham SS, Praharaj SK, Shreekantiah U, Sreeraj VS, Roy C, Shenoy S, Purohith AN, Chithra U, Bagali KB, Venkataramaiah S, Nanjundaiah GKK, Thennarasu K, Kumar CN, Goyal N, Das B, Mehta UM, Muralidharan K, Venkatasubramanian G, Sinha P, Thirthalli J. Clinical efficacy and neurobiological correlates of electroconvulsive therapy in patients with clozapine-resistant/intolerant schizophrenia: study protocol of multi-site parallel arm double-blind randomized sham-controlled study. Wellcome Open Res 2022;7:212. [DOI: 10.12688/wellcomeopenres.18028.1] [Reference Citation Analysis]
|